Mirum Pharmaceuticals (NASDAQ:MIRM) delivers shareholders solid 23% CAGR over 5 years, surging 11% in the last week alone

Investing in shares carries risks, but can also lead to substantial gains. Mirum Pharmaceuticals saw its share price increase by 185% in the last five years. Although the company didn't profit recently, strong revenue growth and insider buying indicate potential for growth.